Cover Image
市場調查報告書

臨床診斷的APAC (亞太地區) 市場:2015∼2019年

Clinical Diagnostics Market in APAC - Market Analysis 2015-2019

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 341720
出版日期 內容資訊 英文 64 Pages
訂單完成後即時交付
價格
Back to Top
臨床診斷的APAC (亞太地區) 市場:2015∼2019年 Clinical Diagnostics Market in APAC - Market Analysis 2015-2019
出版日期: 2015年10月07日 內容資訊: 英文 64 Pages
簡介

APAC (亞太地區) 的臨床診斷市場,預計2014∼2019年關於,12.90%的年複合成長率成長。

本報告提供APAC (亞太地區) 的臨床診斷市場相關分析、市場規模的預測與成長率、主要的市場趨勢、市場成長促進要素與課題、主要供應商、主要供應商的市場機會/威脅/優勢/弱點等相關估計、考察。

第1章 摘要整理

第2章 調查範圍

  • 市場概要
  • 主要供應商的產品

第3章 市場調查手法

  • 調查手法
  • 經濟指標

第4章 簡介

第5章 市場形勢

  • 市場概要
  • 市場規模、預測
  • 波特的五力分析

第6章 法規服務的影響

  • 臨床診斷設備相關法規服務的影響

第7章 臨床診斷:產品平台

  • 臨床診斷:產品平台

第8章 市場區隔:各產品

  • APAC的免疫診斷市場
  • APAC的POC診斷市場
  • APAC的分子診斷市場
  • APAC的血液設備市場
  • APAC的細胞診斷市場
  • APAC的臨床微生物學市場

第9章 推動市場的要素

  • 致死疾病的早期、正確的診斷
  • 市場擴大
  • POC家庭診斷
  • 政府資金
  • 中國設備的國內製造

第10章 促進要素的影響

第11章 市場課題

  • 基礎設施、熟練專家的不足
  • 智慧財產權的問題
  • 偽造IVD產品的可用性
  • 傳統診斷的不正確性
  • 中國的價格政策、不利的醫療費償付政策

第12章 促進要素、課題的影響

第13章 市場趨勢

  • 民營化、醫療保險
  • 抗生素抗性病原菌的出現
  • 個體化醫療
  • 下一代技術、DNA微陣列
  • 當地經銷商為居間人

第14章 業者情勢

  • 競爭情形
  • 市場佔有率分析
  • 其他有潛力的供應商

第15章 主要供應商分析

  • Abbott Diagnostics
  • bioMerieux
  • Beckman Coulter
  • Qiagen
  • Roche Diagnostics

第16章 附錄

第17章 關於Technavio

圖表一覽

目錄
Product Code: IRTNTR7299

About clinical diagnostics

Clinical diagnostics or in-vitro diagnostics is a method to perform diagnostics tests by using instruments, assay reagents, and systems to diagnose a disease or medical condition in a laboratory. Early and accurate diagnosis of life-threatening diseases such as cancer, cardiovascular disease, and influenza will boost the sales of clinical diagnostics products. Factor such as a rapid increase in the number of people with diabetes in developing countries such as in India will increase the sales of diagnostics as there are 50 million diabetes patients. Diabetes can increase the risk of active TB, and this infection can worsen the blood glucose level. To handle this types of medical cases, rapid molecular TB diagnosis is done.

Technavio's analysts forecast the clinical diagnostics market in APAC to grow at a CAGR of 12.90% over the period 2014-2019.

Covered in this report

The report covers the current scenario and the growth prospects of the clinical diagnostics market in APAC for the period of 2015-2019. To calculate the market size, the report considers revenue generated through the sales of diagnostic kits, instruments, and reagents:

  • POC
  • Tissue diagnostic
  • Clinical microbiology
  • Immunodiagnostics
  • Molecular diagnostic
  • Hematology

Technavio's report, Clinical Diagnostics Market in APAC 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers APAC; it also covers the landscape of the clinical diagnostic market in APAC and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key vendors

  • Abbott
  • Beckman Coulter Diagnostics
  • Biomerieux
  • Qiagen
  • Roche

Other Prominent Vendors

  • Amgenix International
  • BD
  • Cepheid
  • DiagCor
  • Hologic
  • J. Mitra
  • Landwind Medical
  • Life Technologies
  • Mindray
  • Randox Laboratories
  • Snibe Diagnostics
  • Span Diagnostics
  • Sysmex
  • Tosoh
  • Trivitron Healthcare
  • URIT

Key market driver

  • Early and accurate diagnosis of life-threatening diseases
  • For a full, detailed list, view our report

Key market challenge

  • Lack of infrastructure and trained professionals
  • For a full, detailed list, view our report

Key market trend

  • Privatization and healthcare coverage
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Impact of regulatory services

  • Impact of regulatory services on clinical diagnostic devices

PART 07: Clinical diagnostics: Product pipeline

  • Clinical diagnostics: Product pipeline

PART 08: Market segmentation by product

  • Immunodiagnostics market in APAC
  • POC diagnostics market in APAC
  • Molecular diagnostics market in APAC
  • Hematology devices market in APAC
  • Tissue diagnostics market in APAC
  • Clinical microbiology systems market in APAC

PART 09: Market drivers

  • Early and accurate diagnosis of life-threatening diseases
  • Market expansion
  • POC home diagnostics
  • Government funding
  • Domestic manufacturing of devices in China

PART 10: Impact of drivers

PART 11: Market challenges

  • Lack of infrastructure and skilled professionals
  • Issues with intellectual property rights
  • Availability of counterfeit IVD products
  • Inaccuracy of conventional diagnostics
  • Pricing policies and unfavorable reimbursement policies in China

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Privatization and healthcare coverage
  • Emergence of antibiotic-resistant pathogens
  • Personalized medicines
  • Next-generation technology and DNA microarrays
  • Local distributors as intermediaries

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2014
  • Other prominent vendors

PART 15: Key vendor analysis

  • Abbott Diagnostics
  • bioMerieux
  • Beckman Coulter
  • Qiagen
  • Roche Diagnostics

PART 16: Appendix

  • List of abbreviations

PART 17: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Clinical diagnostics market in APAC 2014-2019 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Regulatory bodies and their policies for clinical diagnostic devices in APAC
  • Exhibit 05: Clinical diagnostics pipeline of various companies
  • Exhibit 06: Segmentation of clinical diagnostics market in APAC by product
  • Exhibit 07: Segmentation of clinical diagnostics market in APAC by product 2014
  • Exhibit 08: Immunodiagnostics market in APAC 2014-2019 ($ billions)
  • Exhibit 09: POC diagnostics market in APAC 2014-2019 ($ billions)
  • Exhibit 10: Molecular diagnostics market in APAC 2014-2019 ($ millions)
  • Exhibit 11: Hematology devices market in APAC 2014-2019 ($ billions)
  • Exhibit 12: Tissue diagnostics market in APAC 2014-2019 ($ millions)
  • Exhibit 13: Clinical microbiology systems market in APAC 2014-2019 ($ millions)
  • Exhibit 14: Impact of drivers
  • Exhibit 15: Impact of drivers and challenges
  • Exhibit 16: Abbott Diagnostics: Key takeaways
  • Exhibit 17: Beckman Coulter: Key takeaways
  • Exhibit 18: bioMerieux: Key takeaways
  • Exhibit 19: Qiagen: Key takeaways
  • Exhibit 20: Roche Diagnostics: Key takeaways
Back to Top